ARMANDO JULIAO
@ARMANDOJULIAO
Followers
566
Following
1K
Media
34
Statuses
307
Cirujano Urólogo - Urocentro & Director Servicio Urología Clinica Portoazul
Barranquilla, Colombia
Joined June 2011
Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis
jamanetwork.com
This randomized, noninferiority trial of biopsy-naive men compares the detection of Gleason Grade Group ≥2 prostate cancer using microultrasonography-guided and MRI fusion-guided biopsy.
0
0
5
Wide variety of opinions, specialties, patient perspectives, policy makers contributing discussion to a public health conundrum: save lives from PrCa while minimizing overDxRx https://t.co/35xIilgIvP
academic.oup.com
Abstract. Prostate cancer (PC) is a major cause of cancer-related deaths worldwide, with far more diagnoses than deaths annually. Recent discussions have c
1
8
38
Happy and honored to co-host the 5th SCU-NYU Course with my friend Samir Taneja . @tanejauro
instagram.com
1
1
11
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study - The Lancet Oncology https://t.co/RGGKGiQTnp. What’s next ??
0
2
10
Enucleacion tumoral de riñon sin sutura cero isquemia https://t.co/u7S6qvRlj3 vía @YouTube Opción para NxPxLap De tumores con RENAL bajos y mínima penetración al parenquima Renal .
0
0
2
Can AI Revolutionize Prostate Cancer Detection? 🖥️New study shows AI's superior performance in detecting clinically significant prostate cancer on MRI using PI-RADS 2.1. 🖥️Potentially reducing overdiagnosis and easing radiologist workload. Prospective validation is needed
2
25
70
This short story from @JamesClear newsletter describes perfectly the #HoLEP learning curve… #HoLEP
#LearningCurve
#AllDetailsMatter
#MiLEP
#EnBloc
#EarlyApicalRelease
1
11
56
Fantastic lecture by Visiting Professor @peggypearlemd on optimizing outcomes with ureteroscopy including minimizing residual fragments (especially >2mm) and some of the exciting new technologies to help with stone free rates! Shout out to the great work by @OTRAXER @NakadaSteve
2
4
38
A cautionary tale on discordance between PET vs conventional imaging — need more data on implications for #prostatecancer management @DRathkopf #APCCC24
0
7
16
Patients >75 with mHSPC, Darolutamide is the preferred ARPI choice due to its efficacy and safety profile; But en Low Burden? Still? cc @APCCC_Lugano
0
1
3
V nice message from @BJUIjournal that our acute colic nomogram based on the @BURSTurology #MIMIC data is a #TopDownloadedArticle in the journal https://t.co/hcKYCBTuBR Great teamwork and of course glad that the @BJUIjournal benefits too! @TaimurShah @veerukasi @prokarurol
2
26
68
Pattern 3 prostate disease cannot metastasize to nodes (Ross et al 2012), or seminal vesicles. But, rarely, it penetrates the capsule. New evidence suggests that this is not biologically relevant: EPE in Gleaosn 6 doesn't raise BCR risk @uroegg
auajournals.org
Purpose:We sought to examine the association of extraprostatic extension (EPE) with biochemical recurrence (BCR) separately in men with Grade Group (GG) 1 and GG2 prostate cancer (PCa) treated with...
1
15
57
Insightful and provocative talk from the one and only @AndreaNecchi visiting @MoffittNews today. Thinking about upcoming paradigm shaping studies in #bladdercancer and #penilecancer. Super thrilled for the road ahead!
2
7
36
All-star team of authors in a mini-debate on screening/management of PrCa: https://t.co/mR171thDKF
https://t.co/Jrb8jKEyTi
@Alice_YuMD @laherrel @DDJoyce_BFA @UroOncJT @chrisfilson_uro @wayne_brisbane
auajournals.org
1
5
21
Still 40% of patients with low risk prostate cancer getting treated. What a disaster.
Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data Base https://t.co/gKdlDSVpOj
@EdoardoBeatrici @mdlabban @DkFilipas @GLughezzani @NBuffi @adamkibel_uro @Putnam_Cole @qdtrinh
7
12
56
💫🌟Immunotherapy in the Treatment of Localized Genitourinary Cancers🌟💫 📣👩🎓👨🎓Must Read👇📚 Excellent Article!! @AndreaNecchi
@FaltasLab @montypal @JAMAOnc 🔬 Advancements in localized genitourinary cancer treatment! 🌟Key insights from the article: 1️⃣ Immunotherapy (IO)
0
14
29
11
221
763
Check out our collaborative review on cytoreductive nephrectomy in the checkpoint inhibitor era https://t.co/n9qAmjTsxW
@ejasonabel @SpiessPhilippe @virajmaster @SurenaMatinMD @jadchahoud #BrandonManley #JoseKaram
0
16
46